Vaxcyte Inc (PCVX)
Vaxcyte stock today
Vaxcyte closed at $62.03 on October 30, 2026, down 0.93% on the day. Over the past year it returned +38.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.96 billion.
| Period | PCVX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +9.0% | -0.9% |
| 3 months | +10.8% | +2.1% |
| Year to date | +34.4% | +11.7% |
| 1 year | +38.6% | +12.4% |
| 3 years | +30.3% | +88.5% |
| 5 years | +165.1% | +76.0% |
Key statistics
- Market value
- $8.96B
- 52-week range
- $40.32 to $73.82
- Next report
- Nov 3, 2026 (estimated)
About Vaxcyte
Vaxcyte develops recombinant vaccines for infectious diseases.
Sector: Health Care
More on Vaxcyte
- Returns: what $1,000 became$1,000 five years ago is $2,651 today
No forecast, no recommendation. This page describes Vaxcyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.